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Introduction {#iid3175-sec-0005}
============

Perioperative hypersensitivity reactions can be life‐threatening. The incidence of such reactions is estimated 1 in 13,000 anesthetics up to 1 in 3180 [1](#iid3175-bib-0001){ref-type="ref"}. Neuromuscular blocking agents (NMBA), antibiotics, induction agents, and opiates are the most common substances, but there is a substantial geographic dfference in the major causes of perioperative anaphylaxis [2](#iid3175-bib-0002){ref-type="ref"}. An allergy work‐up to identify the culprit drugs is required to avoid anaphylactic episodes during anesthesia in the future. However, several problems hamper the success in many cases [3](#iid3175-bib-0003){ref-type="ref"}.

The history of the reaction is mostly based on anesthesia records which contain ideally the time point of the reaction, the type of reactions, and all given substances, but this is not always documented as it is required. Hidden substances may also cause anaphylaxis. Positive reactions to skin tests with anesthetic agents are below 5% in normal controls at defined concentrations, but exceeding the recommended maximum concentrations can lead to false positive reactions [4](#iid3175-bib-0004){ref-type="ref"}. Also for some antibiotics (e.g. ciprofloxacin) irritating concentrations in healthy volunteers are reported. Determination of sIgE is commercially available only for some antibiotics (e.g. amoxicillin, ampicillin, penicilloyl G, penicilloyl V (ImmunoCAP, ThermoFisher, Freiburg, Germany) and has a low sensitivity of less than 40%. Furthermore provocation tests---the gold standard of allergy diagnosis---cannot be performed with NMBA and induction agents.

In addition to these tests the basophil activation test (BAT) can be part of the diagnostic evaluation of drug allergy [5](#iid3175-bib-0005){ref-type="ref"}. This cellular in vitro test measures basophil response to allergen cross‐linking IgE on basophil granulocytes. For NMBA, antibiotics and analgesics positive results in the BAT were published [6](#iid3175-bib-0006){ref-type="ref"}, [7](#iid3175-bib-0007){ref-type="ref"}. It was the aim of this study to investigate the relevance of the BAT for clinical routine allergy diagnosis in patients with perioperative anaphylactic reactions.

Methods {#iid3175-sec-0006}
=======

A total of 14 patients (5 males, 9 females; age: 22--77 years) with a clear history of perioperative anaphylactic reactions recruited consecutively in our allergy unit were included in the study. Two had systemic immediate type reactions of severity grade I, four of severity grade II, four of severity grade III, and four of severity grade IV according to the classification of Ring and Messmer [8](#iid3175-bib-0008){ref-type="ref"}. Controls for the BAT comprised 11 individuals (6 males, 5 females, 22--50 years) with a negative history for a perioperative anaphylactic reaction. The study protocol was in accordance with the local ethical committee guidelines and all subjects had given informed consent before being included. Skin prick tests (SPT) and intradermal tests (IDT) were performed. In dependence on the history and the anesthetic protocol the tested drugs included standard blocks of analgesics (acetylsalicylic acid, celecoxib, diclofenac, ibuprofen, indometacin, metamizole, paracetamol, propyphenazone, tramadol), standard blocks of antibiotics (PPL (benzylpenicilloyl polylysine), MDM (minor determinant mixture), amoxicillin, cefuroxime, ciprofloxacin, doxycycline, erythromycin, roxithromycin, sulfamethoxazole, trimethoprim), standard blocks of local anesthetics (articaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, methyl‐4‐hydroxybenzoate), standard blocks of narcotics and NMBA: atracurium, cisatracurium, etomidate, neostigmine, midazolam, mivacurium, pancuronium, propofol, pyridostigmine, succinylcholine, sufentanil, thiopental, vecuronium), and further individual substances, for example, ampicillin, chlorhexidine, clindamycin, dexamethasone, fentanyl, latex, macrogol, metoclopramide, MOVIPREP® (Norgine GmbH, Marburg, Germany), octenisept® (Schülke & Mayr GmbH, Noderstedt, Germany), omeprazole, pantoprazole, patent blue, remifentanil, or rocuronium. SPT were read after 15 min and considered positive when the mean diameter of the wheal and flare reactions was equal or greater than 3 mm.

In patients with negative SPT IDT was done on the ventral aspect of the forearm with part of the above mentioned drugs (antibiotics, local anesthetics, narcotics, NMBA) at lower concentrations (Table [1](#iid3175-tbl-0001){ref-type="table-wrap"}). IDT were considered to be positive, when the difference to control was greater than 3 mm. Specific IgE‐antibodies against amoxicillin, ampicillin, chlorhexidine, penicillin G, penicillin V, morphine, and latex were perfomed using the system UniCAP 250 (ThermoFisher) in 11 patients. Values of specific IgE below 0.35 kU/L were considered negative.

###### 

Concentrations of the tested standard allergens in skin prick test (SPT) and intradermal test (ID)

  Substance                            SPT            ID
  ------------------------------------ -------------- ------------------
  Analgesics                                          
  Acetyl salicylic acid                Pure in NaCl   n.d.
  Celecoxib                            Pure in NaCl   n.d.
  Diclofenac                           Pure in NaCl   n.d.
  Ibuprofen                            Pure in NaCl   n.d.
  Indometacin                          Pure in NaCl   n.d.
  Metamizole                           Pure in NaCl   n.d.
  Paracetamol                          Pure in NaCl   n.d.
  Propyphenazone                       Pure in NaCl   n.d.
  Tramadol                             Pure in NaCl   n.d.
  Antibiotics                                         
  PPL (benzylpenicilloyl polylysine)   Undiluted      1:10, undiluted
  MDM (minor determinant mixture)      Undiluted      1:100, undiluted
  Amoxicillin                          Pure in NaCl   0.1%
  Cefuroxime                           Pure in NaCl   0.1%
  Ciprofloxacin                        Pure in NaCl   n.d.
  Doxycycline                          Pure in NaCl   n.d.
  Erythromycin                         Pure in NaCl   n.d.
  Roxithromycin                        Pure in NaCl   n.d.
  Sulfamethoxazole/Trimethoprim        Pure in NaCl   n.d.
  Local anesthetics                                   
  Articaine                            2%             0.1%
  Bupivacaine                          0.5%           0.1%
  Lidocaine                            2%             0.1%
  Mepivacaine                          2%             0.1%
  Prilocaine                           2%             0.1%
  Procaine                             2%             0.1%
  Methyl‐4‐hydroxybenzoate             0.1%           0.1%
  Narcotics and NMBA                                  
  Atracurium 10 mg/mL                  Undiluted      1:100
  Cicatracurium 2 mg/mL                Undiluted      1:100
  Etomidate 2 mg/mL                    Undiluted      1:10
  Neostigmine 0.5 mg/mL                Undiluted      1:100
  Midazolam 5 mg/mL                    Undiluted      0:10
  Mivacurium 2 mg/mL                   Undiluted      1:1000
  Pancouronium 2 mg/mL                 Undiluted      1:10
  Propofol 10 mg/mL                    Undiluted      1:10
  Pyridostigmine 5 mg/mL               Undiluted      1:100
  Succinylcholine 2 mg/mL              Undiluted      1:100
  Sufentanil 0.005 mg/mL               Undiluted      1:10
  Thiopental 25 mg/mL                  Undiluted      1:100
  Vecuronium 2 mg/mL                   Undiluted      1:10

n.d., not done.
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The Flow2 CAST® (BÜHLMANN Laboratories AG, Schönenbuch, Switzerland) was performed as previously described [9](#iid3175-bib-0009){ref-type="ref"} with the following substances (in dependence on the history and the results of the skin tests): Analgesics (fentanyl, metamizole, paracetamol, piritramide, remifentanil, sufentanil, tramadol), antibiotics (ampicillin, cefazolin, cefuroxime, ciprofloxacin, clindamycin, PPL, MDM), local anesthetics (bupivacaine, lidocaine, mepivacaine, ropivacaine), narcotics (etomidate, midazolam, propofol, pyridostigmine, thiopental), NMBA (atracurium, cisatracurium, mivacurium, neuromuscular blocking mix, pancuronium, rocuronium, suxamethonium, vecuronium), and others (dexamethasone, hydroxyethyl starch \[HES\], patent blue, suprarenin). Concentrations used are listed in Table [2](#iid3175-tbl-0002){ref-type="table-wrap"}. In order to consider the results as positive a cut‐off ≥5 % activated basophils and a stimulation index ≥2 (SI = allergen stimulation divided by negative control) was used.

###### 

Concentrations (after reconstitution) of the tested allergens in BAT. For concentrations in stimulation values have to be divided by 4.4

  Substance                                                            Concentration 1                                            Concentration 2
  -------------------------------------------------------------------- ---------------------------------------------------------- ----------------------------------------------------------
  Analgesics                                                                                                                      
  Fentanyl[^a^](#iid3175-note-0002){ref-type="fn"}                     500--1040 ng/mL[^c^](#iid3175-note-0004){ref-type="fn"}    250--500 ng/mL[^c^](#iid3175-note-0004){ref-type="fn"}
  Metamizole[^b^](#iid3175-note-0003){ref-type="fn"}                   50 μg/mL                                                   10 μg/mL
  Paracetamol[^b^](#iid3175-note-0003){ref-type="fn"}                  10 μg/mL                                                   2 μg/mL
  Piritramide[^a^](#iid3175-note-0002){ref-type="fn"}                  5.5 μg/mL                                                  1.1 μg/mL
  Remifentanil[^a^](#iid3175-note-0002){ref-type="fn"}                 60 ng/mL                                                   30 ng/mL
  Sufentanil[^a^](#iid3175-note-0002){ref-type="fn"}                   440--640 ng/mL[^c^](#iid3175-note-0004){ref-type="fn"}     220--320 ng/mL[^c^](#iid3175-note-0004){ref-type="fn"}
  Tramadol[^a^](#iid3175-note-0002){ref-type="fn"}                     100 mg/mL                                                  20 mg/mL
  Antibiotics                                                                                                                     
  Ampicillin[^b^](#iid3175-note-0003){ref-type="fn"}                   10 mg/mL                                                   2 mg/mL
  Cefazolin[^b^](#iid3175-note-0003){ref-type="fn"}                    2.5 mg/mL                                                  0.5 mg/mL
  Cefuroxime[^b^](#iid3175-note-0003){ref-type="fn"}                   2.5 mg/mL                                                  0.5 mg/mL
  Ciprofloxacin[^b^](#iid3175-note-0003){ref-type="fn"}                100 μg/mL                                                  20 μg/mL
  Clindamycin[^a^](#iid3175-note-0002){ref-type="fn"}                  220 μg/mL                                                  110 μg/mL
  PPL[^b^](#iid3175-note-0003){ref-type="fn"}                          50 μg/mL                                                   10 μg/mL
  MDM[^b^](#iid3175-note-0003){ref-type="fn"}                          1 mg/mL                                                    0.2 mg/mL
  Local anesthetics                                                                                                               
  Bupivacaine[^b^](#iid3175-note-0003){ref-type="fn"}                  400 μg/mL                                                  80 μg/mL
  Lidocaine[^b^](#iid3175-note-0003){ref-type="fn"}                    250 μg/mL                                                  50 μg/mL
  Mepivacaine[^b^](#iid3175-note-0003){ref-type="fn"}                  400 μg/mL                                                  80 μg/mL
  Ropivacaine[^a^](#iid3175-note-0002){ref-type="fn"}                  800 μg/mL                                                  400 μg/mL
  Narcotics                                                                                                                       
  Etomidate[^a^](#iid3175-note-0002){ref-type="fn"}                    2.94 μg/mL                                                 1.47 μg/mL
  Midazolam[^a^](#iid3175-note-0002){ref-type="fn"}                    11 ng/mL                                                   5.5 ng/mL
  Propofol[^b^](#iid3175-note-0003){ref-type="fn"}                     1 mg/mL                                                    0.2 mg/mL
  Pyridostigmine[^a^](#iid3175-note-0002){ref-type="fn"}               22 μg/mL                                                   11 μg/mL
  Thiopental[^a^](#iid3175-note-0002){ref-type="fn"}                   0.38--0.44 mg/mL[^c^](#iid3175-note-0004){ref-type="fn"}   0.19--0.22 mg/mL[^c^](#iid3175-note-0004){ref-type="fn"}
  NMBA                                                                                                                            
  Atracurium[^b^](#iid3175-note-0003){ref-type="fn"}                   5 μg/mL                                                    1 μg/mL
  Cisatracurium[^b^](#iid3175-note-0003){ref-type="fn"}                400 μg/mL                                                  80 μg/mL
  Mivacurium[^b^](#iid3175-note-0003){ref-type="fn"}                   1 mg/mL                                                    0.2 mg/mL
  Neuromuscular blocking mix[^b^](#iid3175-note-0003){ref-type="fn"}   4.3 mg/mL                                                  0.86 mg/mL
  Pancuronium[^b^](#iid3175-note-0003){ref-type="fn"}                  1 mg/mL                                                    0.2 mg/mL
  Rocuronium[^b^](#iid3175-note-0003){ref-type="fn"}                   1 mg/mL                                                    0.2 mg/mL
  Suxamethonium[^b^](#iid3175-note-0003){ref-type="fn"}                10 mg/mL                                                   2 mg/mL
  Vecuronium[^b^](#iid3175-note-0003){ref-type="fn"}                   250 μg/mL                                                  50 μg/mL
  Others                                                                                                                          
  Dexamethasone[^a^](#iid3175-note-0002){ref-type="fn"}                5.86 μg/mL                                                 2.93 μg/mL
  Hydroxyethyl starch[^a^](#iid3175-note-0002){ref-type="fn"}          60 μg/mL                                                   12 μg/mL
  Patent blue V[^b^](#iid3175-note-0003){ref-type="fn"}                250 μg/mL                                                  50 μg/mL
  Suprarenin[^a^](#iid3175-note-0002){ref-type="fn"}                   0.146 μg/mL                                                0.073 μg/mL

Commercially available medication.

Purchased from BÜHLMANN Laboratories AG, Schönenbuch, Switzerland.

Concentration depending on body weight of the patient.
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Results {#iid3175-sec-0007}
=======

Analgesics were used in history in four patients with three patients showing positive results in the SPT to metamizole and one patient to tramadol. Antibiotics were given in history in nine patients. Out of the 14 patients tested six cases showed positive results in the SPT to amoxicillin, ampicillin, cefuroxime, ciproflocaxin, clindamycin, doxycycline, or PPL and two cases in the IDT to cefuroxime or MDM. One patient had sIgE antibodies to betalactams (CAP class 3 to amoxicillin, ampicillin, penicilloyl G, penicilloyl V). Local anesthetics were given in history in five patients, none of them had a positive skin test reaction. Narcotics were used in history in all cases. One patient had a positive SPT to propofol and 11 patients positive IDTs to etomidate, midazolam, pyridostigmine, succinylcholine, or thiopental. NMBA were used in history in eight patients. Out of the 14 patients six cases showed positive results in the SPT and 10 cases in the IDT to atracurium, cisatracurium, mivacurium, pancuronium, succinylcholine, or vecuronium. SIgE to morphine was negative in all cases. Other substances involved were SPT positive in two cases (patent blue and latex).

Three patients showed positive results in the BAT: One patient revealed a basophil activation of 49.1% to metamizole (SI = Stimulation Index: 114.2) at a concentration (after reconstitution) of 50 μg/mL, another patient showed a basophil activation of 7.8% (SI 39.2), and 22.1% to PPL (SI 110.9) at two different concentrations (50 and 10 μg/mL after reconstitution), respectively and one patient revealed an activation of 7.8% (SI 11.2) to pancuronium at a concentration of 0.2 mg/mL after reconstitution. BATs with these substances were negative in controls. Comparisons of the positive results in the different tests are listed in Table [3](#iid3175-tbl-0003){ref-type="table-wrap"}.

###### 

Number of patients with the substance group used in anesthesia, number of positive reactions in skin tests, determination of specific IgE and basophil activation tests (Flow2 CAST®) in the study group (*n* = 14)

                             Analgesics   Antibiotics   Local anesthetics   Narcotics   NMBA
  -------------------------- ------------ ------------- ------------------- ----------- ------
  History                    4            9             5                   14          8
  Prick test                 4            6             0                   1           6
  Intradermal test           n.d.         2             0                   11          10
  sIgE                       n.a.         1             n.a.                n.a.        n.a.
  Basophil activation test   1            1             0                   1           0

n.a., not applicable; n.d., not done.
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Discussion {#iid3175-sec-0008}
==========

This study shows a discrepancy between the number of positive reactions in skin testing and number of positive results in BAT. This might be due to different reasons: On the one hand non‐IgE mediated mechanisms or irritative reactions of drugs (especially of narcotics and NMBA in the intracutaneous test) may lead to positive skin test results which cannot be recovered in vitro. This is supported by the negative results in IgE morphine determination being a very sensitive biomarker for quaterny ammonium sensitization in case of suspected hypersensitivity to NMBA [10](#iid3175-bib-0010){ref-type="ref"}. On the other hand IgE‐mediated reactions which were found for betalactams and metamizole in the BAT in two cases seem to be less frequent in perioperative reactions. Furthermore sensitivity for betalactams and metamizole in the BAT is about 40--50% [9](#iid3175-bib-0009){ref-type="ref"}, [11](#iid3175-bib-0011){ref-type="ref"}. Therefore the culprit agent would have not been detected by BAT in 50--60% of the cases. As specificity for both drugs is high (80% fo betalactams, 100% to metamizole), a positive BAT points out the relevant substance. This was underlined in our two cases by a positive skin test to amoxicillin, ampicillin, PPL and sIgE to amoxicillin, ampicillin, penicilloyl B, and penicilloyl V in the one case (eliciting drug ampicillin) and a convincing history (two anaphylactic reactions in which metamizole was involved) as well as a positive skin test to metamizole in the other case. In the third case pancuronium (not atracurium, cisatracurium, mivacurium or vencuronium) showed a positive result in the BAT, but the NMBA given during anesthesia was cisatracurium and the intracutaneous test was positive to atracurium, mivacurium, and pancuronium. Cross‐reactivity among these substances can be assumed. For NMBA it was shown that skin test and BAT have an excellent negative predictive value especially if rocuronium was involved [6](#iid3175-bib-0006){ref-type="ref"}.

The BAT should be used complementary to skin tests in patients with perioperative anaphylactoid reactions, especially if IgE‐mediated mechanisms are presumed and skin tests are inconclusive. Due to a good specificity a positive reaction with a high activation in BAT identifies the culprit agent in perioperative hypersensitivity reactions with high probability. This is advantageous in cases where a provocation test cannot be performed due to the drug effect (e.g. in NMBA). In other cases drug challenges that are time consuming, expensive and risky with regard to severe allergic reactions can be deferred or avoided (e.g. in case of urgent treatments under anesthesia). Furthermore BAT is also applicable in patients with contraindications for skin or provocation tests (e.g. intake of β‐blockers or ACE inhibitors).

Conflicts of Interest {#iid3175-sec-0010}
=====================

None declared.

We would like to thank Franziska Martin for her excellent technical support.
